Cholestyramine

BreastfeedingPediatric
  • TRADE NAMES: Chol-Less; Colestrol; Lismol; PMS-Cholestyramine; Prevalite; Quantalan; Questran (Par); Questran Lite
  • INDICATIONS: Pruritus associated with biliary obstruction, primary hypercholesterolemia
  • CLASS: Bile acid sequestrant
  • HALF-LIFE: N/A

Contra-indicated in patients with complete biliary obstruction.

Our database has 14 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top